Zomato's Deepinder Goyal Responds to Critics of Unreleased 'Temple' Health Device
Deepinder Goyal has defended Zomato's unreleased 'Temple' brain monitoring device against criticism from doctors and influencers. The Zomato co-founder emphasized that no commercial announcements have been made and official benchmarking data has not been released, with months of development work still remaining. Goyal called for critics to wait for official scientific data before making judgments and urged support for Indian startup innovation.
*this image is generated using AI for illustrative purposes only.
Zomato co-founder Deepinder Goyal has issued a strong response to doctors and influencers who have been criticizing the company's upcoming 'Temple' health device. In a post on social media platform X, Goyal questioned the timing of such criticism for a product that remains unavailable to consumers.
Goyal's Response to Premature Criticism
Goyal directly addressed the critics in his social media post, stating: "You are advising people not to buy an 'unvalidated' device that isn't even available to order or pre-order yet. That's funny, tbh." The Zomato chief emphasized that such judgment appears premature given the product's current development status.
The entrepreneur outlined the current state of the Temple project, clarifying several key points about the device's availability and development timeline:
| Development Status: | Details |
|---|---|
| Commercial Announcements: | None made publicly |
| Official Benchmarking Data: | Not yet released |
| Timeline to Public Preview: | Months away |
| Current Status: | Significant work still underway |
Call for Patience and Support
Goyal urged medical professionals and influencers to withhold their skepticism until the company provides official information about the device. "We will share all the science if and when we decide to sell Temple. You can judge and give all your advice at that moment. Until then, be curious, and cheer Indian startups?" he stated.
The Zomato founder acknowledged the value of expert skepticism while emphasizing the importance of timing, noting that such criticism would be more appropriate once official data becomes available.
About the Temple Device
The 'Temple' device was first introduced during Goyal's appearance on Raj Shamani's 'Figuring Out' podcast, where he was seen wearing the prototype. According to Goyal's previous explanations, the specialized health-tech device functions as a brain monitoring tool with specific capabilities:
- Measures blood flow in the brain
- Operates similar to a "miniaturised" MRI
- Designed to help users monitor brain health
- Linked to maintaining better health through improved brain blood flow
Goyal had previously explained that the device connects to the Gravity Aging Hypothesis, which proposes that gravity reduces blood flow to the brain, potentially contributing to the aging process. The entrepreneur suggested that activities aimed at keeping "brain flow up" could help individuals feel better and maintain healthier lives over time.
Industry Context
The exchange highlights the challenges faced by Indian startups when developing innovative health technology products. Goyal's response reflects the tension between maintaining scientific rigor and supporting domestic innovation in the competitive health-tech sector.
The Zomato co-founder's call for patience underscores the importance of allowing companies to complete their development processes and provide comprehensive data before facing public scrutiny. His emphasis on supporting Indian startups suggests a broader conversation about fostering innovation in the country's technology ecosystem.
17
